Osteo expenses hold back CompuMed performance
This article was originally published in Clinica
Executive Summary
Diagnostics software solutions company CompuMed (Los Angeles, California) says that an increase in staff numbers to accelerate the development of its OsteoGram osteoporosis range was the reason for a 14% rise in the net loss for 2005 to $336,000. Sales of the range fell by 22%, to $118,000, as a result of slower-than-anticipated implementation by CompuMed's OEM partners.